Showing 1 - 5 results of 5 for search 'Chikako Funasaka', query time: 0.01s Refine Results
  1. 1
    Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study

    Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study by Honami Katahara, Kaede Baba, Hiromichi Nakajima, Hiromichi Nakajima, Hiromichi Nakajima, Chikako Funasaka, Chikako Funasaka, Chihiro Kondoh, Yoichi Naito, Yoichi Naito, Yoichi Naito, Hibiki Udagawa, Kohei Shitara, Tomoaki Sasaki, Toshikatsu Kawasaki, Toru Mukohara

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)

    Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr) by Chikako Funasaka, Chikako Funasaka, Yoichi Naito, Yoichi Naito, Yoichi Naito, Hitomi Kubota, Yukiko Ishiguro, Nozomu Fuse, Masashi Wakabayashi, Akihiro Sato, Junichiro Yuda, Junichiro Yuda, Genichiro Ishii, Toshihiro Suzuki, Kazumasa Takenouchi, Tetsuya Nakatsura, Konomi Morita, Yoichi Inada, Miyuki Tanaka, Miyuki Tanaka, Miyuki Tanaka, Yozo Nakazawa, Yozo Nakazawa, Shigeki Yagyu, Shigeki Yagyu, Toshihiko Doi

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case Report

    Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case Report by Aoi Kuroda, Mao Uematsu, Mai Shimura, Akira Hirota, Misao Fukuda, Nobuyuki Takahashi, Hiromichi Nakajima, Chikako Funasaka, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Ako Hosono, Yoichi Naito, Toru Mukohara

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer

    The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer by Chikako Funasaka, Takahiro Kogawa, Naoya Sakamoto, Shota Kusuhara, Takehiro Nakao, Hiromichi Nakajima, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Ako Hosono, Yoichi Naito, Mototsugu Shimokawa, Rurina Watanuki, Yuji Yamashita, Chisako Yamauchi, Tatsuya Onishi, Genichiro Ishii, Toru Mukohara

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer

    The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer by Shu Kato, Kaede Baba, Kanako Mamishin, Mao Uematsu, Mai Shimura, Akira Hirota, Misao Fukuda, Nobuyuki Takahashi, Takehiro Nakao, Hiromichi Nakajima, Chikako Funasaka, Chihiro Kondoh, Kenichi Harano, Yoichi Naito, Nobuaki Matsubara, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: